IN2012DN00640A - - Google Patents
Download PDFInfo
- Publication number
- IN2012DN00640A IN2012DN00640A IN640DEN2012A IN2012DN00640A IN 2012DN00640 A IN2012DN00640 A IN 2012DN00640A IN 640DEN2012 A IN640DEN2012 A IN 640DEN2012A IN 2012DN00640 A IN2012DN00640 A IN 2012DN00640A
- Authority
- IN
- India
- Prior art keywords
- variable domains
- hosts
- ligands
- vectors
- compositions
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/55—Fab or Fab'
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/569—Single domain, e.g. dAb, sdAb, VHH, VNAR or nanobody®
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
- C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/31—Fusion polypeptide fusions, other than Fc, for prolonged plasma life, e.g. albumin
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Veterinary Medicine (AREA)
- Mycology (AREA)
- Physics & Mathematics (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Plant Pathology (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US22602809P | 2009-07-16 | 2009-07-16 | |
| US30755410P | 2010-02-24 | 2010-02-24 | |
| PCT/EP2010/060112 WO2011006915A2 (en) | 2009-07-16 | 2010-07-14 | Improved anti-serum albumin binding single variable domains |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2012DN00640A true IN2012DN00640A (enExample) | 2015-08-21 |
Family
ID=42829253
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN640DEN2012 IN2012DN00640A (enExample) | 2009-07-16 | 2010-07-14 |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US8679496B2 (enExample) |
| EP (1) | EP2454285A2 (enExample) |
| JP (1) | JP2012532620A (enExample) |
| KR (1) | KR20120038494A (enExample) |
| CN (1) | CN102574914A (enExample) |
| AU (1) | AU2010272590B2 (enExample) |
| BR (1) | BR112012001681A2 (enExample) |
| CA (1) | CA2768462A1 (enExample) |
| EA (1) | EA201270174A1 (enExample) |
| IL (1) | IL217520A0 (enExample) |
| IN (1) | IN2012DN00640A (enExample) |
| MX (1) | MX2012000765A (enExample) |
| SG (1) | SG177601A1 (enExample) |
| WO (1) | WO2011006915A2 (enExample) |
| ZA (1) | ZA201200276B (enExample) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2011008799A (es) * | 2009-02-19 | 2011-09-27 | Glaxo Group Ltd | Polipeptidos, dominios variables de anticuerpos, y antagonistas anti-tnfr1 mejorados. |
| WO2011006915A2 (en) * | 2009-07-16 | 2011-01-20 | Glaxo Group Limited | Improved anti-serum albumin binding single variable domains |
| EP2603522A1 (en) | 2010-08-13 | 2013-06-19 | GlaxoSmithKline Intellectual Property Development Limited | Improved anti-serum albumin binding variants |
| US20130266567A1 (en) * | 2010-12-01 | 2013-10-10 | Haren Arulanantham | Anti-serum albumin binding single variable domains |
| JP6411214B2 (ja) | 2011-11-11 | 2018-10-24 | ユーシービー バイオファルマ エスピーアールエル | アルブミン結合抗体及びその結合断片 |
| GB201200563D0 (en) * | 2012-01-13 | 2012-02-29 | Imp Innovations Ltd | Binding molecule |
| WO2017041114A2 (en) * | 2015-09-03 | 2017-03-09 | The Children's Mercy Hospital | Anti-nicotinamide phosphoribosyltransferase antibody genes and methods of use thereof |
| NO2768984T3 (enExample) | 2015-11-12 | 2018-06-09 | ||
| HUE057241T2 (hu) * | 2015-11-13 | 2022-04-28 | Ablynx Nv | Javított, szérumalbumint kötõ immunoglobulin variábilis domének |
| IL300122A (en) | 2015-11-18 | 2023-03-01 | Merck Sharp ַ& Dohme Llc | Substances that bind to PD1 and/or LAG3 |
| US10544222B2 (en) | 2015-11-18 | 2020-01-28 | Merck Sharp & Dohme Corp. | PD1/CTLA4 binders |
| AU2016357460B2 (en) | 2015-11-18 | 2023-07-27 | Ablynx Nv | Improved serum albumin binders |
| CN108473565B (zh) | 2015-11-18 | 2022-05-27 | 默沙东公司 | Ctla4结合剂 |
| CN115837014A (zh) | 2016-05-18 | 2023-03-24 | 摩登纳特斯有限公司 | 编码松弛素的多核苷酸 |
| WO2018104444A1 (en) * | 2016-12-07 | 2018-06-14 | Ablynx Nv | Improved serum albumin binding immunoglobulin single variable domains |
| EP3571224B1 (en) | 2017-01-17 | 2024-08-07 | Ablynx NV | Improved serum albumin binders |
| EP4442709A3 (en) * | 2017-01-17 | 2024-12-25 | Ablynx NV | Improved serum albumin binders |
| PT3583125T (pt) | 2017-02-16 | 2025-04-04 | Sonnet Biotherapeutics Inc | Proteínas de fusão ao domínio de ligação à albumina |
| US12202911B2 (en) | 2017-10-10 | 2025-01-21 | Numab Therapeutics AG | Multispecific antibody comprising CD137 binding domain and PDL1 binding domain |
| EP3470426A1 (en) | 2017-10-10 | 2019-04-17 | Numab Therapeutics AG | Multispecific antibody |
| WO2020172528A1 (en) * | 2019-02-22 | 2020-08-27 | Anwita Biosciences, Inc. | Albumin binding antibodies and use thereof |
| EP3816185A1 (en) | 2019-11-04 | 2021-05-05 | Numab Therapeutics AG | Multispecific antibody directed against pd-l1 and a tumor-associated antigen |
| GB201919061D0 (en) | 2019-12-20 | 2020-02-05 | Ucb Biopharma Sprl | Multi-specific antibody |
| WO2021205183A1 (en) | 2020-04-09 | 2021-10-14 | Autolus Limited | Polypeptide |
| GB202007441D0 (en) | 2020-05-19 | 2020-07-01 | Autolus Ltd | Polypeptide |
| EP3915580A1 (en) | 2020-05-29 | 2021-12-01 | Numab Therapeutics AG | Multispecific antibody |
| IT202000013006A1 (it) * | 2020-06-01 | 2021-12-01 | Bioreweal S R L | Processo per la produzione biologica di idrogeno e/o di metano mediante assorbimento e conversione biologica di anidride carbonica. |
| EP3988568A1 (en) | 2020-10-21 | 2022-04-27 | Numab Therapeutics AG | Combination treatment |
| US20240067758A1 (en) | 2020-12-07 | 2024-02-29 | UCB Biopharma SRL | Multi-specific antibodies and antibody combinations |
| JP7858665B2 (ja) | 2021-02-02 | 2026-05-14 | ヌマブ セラピューティックス アーゲー | Ｒｏｒ１およびｃｄ３に対する特異性を有する多重特異性抗体 |
| EP4183800A1 (en) | 2021-11-19 | 2023-05-24 | Medizinische Hochschule Hannover | Novel sars-cov-2 neutralizing antibodies |
| WO2024038095A1 (en) | 2022-08-16 | 2024-02-22 | Iome Bio | NOVEL ANTI-RGMb ANTIBODIES |
| IL322519A (en) | 2023-02-17 | 2025-10-01 | Ablynx Nv | Polypeptides that bind to the neonatal fc receptor |
| WO2025061919A1 (en) | 2023-09-22 | 2025-03-27 | Ablynx Nv | Bi- and multivalent albumin binders |
| US12134635B1 (en) | 2023-12-29 | 2024-11-05 | Sonnet BioTherapeutics, Inc. | Interleukin 18 (IL-18) variants and fusion proteins comprising same |
| TW202608919A (zh) | 2024-04-12 | 2026-03-01 | 美商派拉岡醫療公司 | 白蛋白結合蛋白及使用方法 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL127127A0 (en) | 1998-11-18 | 1999-09-22 | Peptor Ltd | Small functional units of antibody heavy chain variable regions |
| IL159177A0 (en) * | 2001-06-20 | 2004-06-01 | Prochon Biotech Ltd | Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof |
| US20100081792A1 (en) * | 2001-06-28 | 2010-04-01 | Smithkline Beecham Corporation | Ligand |
| CN1678634A (zh) | 2002-06-28 | 2005-10-05 | 多曼蒂斯有限公司 | 免疫球蛋白单个变体抗原结合区及其特异性构建体 |
| US9321832B2 (en) * | 2002-06-28 | 2016-04-26 | Domantis Limited | Ligand |
| ATE479760T1 (de) | 2004-03-24 | 2010-09-15 | Domantis Ltd | Universelles signalpeptid gas1 |
| US8921528B2 (en) | 2004-06-01 | 2014-12-30 | Domantis Limited | Bispecific fusion antibodies with enhanced serum half-life |
| US7563443B2 (en) * | 2004-09-17 | 2009-07-21 | Domantis Limited | Monovalent anti-CD40L antibody polypeptides and compositions thereof |
| GB0521621D0 (en) * | 2005-10-24 | 2005-11-30 | Domantis Ltd | Tumor necrosis factor receptor 1 antagonists for treating respiratory diseases |
| JP5185624B2 (ja) | 2004-12-02 | 2013-04-17 | ドマンティス リミテッド | 血清アルブミンおよびｇｌｐ−１またはｐｙｙを標的とする二重特異性抗体 |
| CA2632866A1 (en) * | 2005-12-01 | 2007-06-07 | Domantis Limited | Noncompetitive domain antibody formats that bind interleukin 1 receptor type 1 |
| JP2009517069A (ja) * | 2005-12-01 | 2009-04-30 | ドマンティス リミテッド | インターロイキン１受容体１型に結合する競合ドメイン抗体フォーマット |
| EP1966242A1 (en) * | 2005-12-06 | 2008-09-10 | Domantis Limited | Ligands that have binding specificity for egfr and/or vegf and methods of use therefor |
| BRPI0710572A2 (pt) * | 2006-01-24 | 2013-01-08 | Domantis Limited | ligante, uso do ligante, mÉtodos para o tratamento de uma doenÇa alÉrgica, de asma e de cÂncer, para a inibiÇço de uma resposta imune do tipo th2, e administraÇço de tratamento anti-il-4 e tratamento anti-il-13, composiÇço farmacÊutica, dispositivo de dispensaÇço de droga, Ácido nucleico isolado ou recombinante, vetor, cÉlula hospedeira, mÉtodos para a produÇço de um ligante e de inibiÇço da proliferaÇço de cÉlulas |
| US20100047171A1 (en) | 2006-01-24 | 2010-02-25 | Roland Beckmann | Fusion Proteins That Contain Natural Junctions |
| CA2688434A1 (en) | 2007-06-06 | 2008-12-11 | Domantis Limited | Polypeptides, antibody variable domains and antagonists |
| WO2009149143A1 (en) * | 2008-06-03 | 2009-12-10 | E. I. Du Pont De Nemours And Company | Adhesion of polyamides to epoxy resins |
| US8906035B2 (en) * | 2008-06-04 | 2014-12-09 | Ethicon Endo-Surgery, Inc. | Endoscopic drop off bag |
| US10198891B2 (en) * | 2008-06-06 | 2019-02-05 | Epona Llc | System and method for regulating fuel transactions |
| BRPI0915681A2 (pt) * | 2008-06-06 | 2015-08-04 | Danisco Us Inc | Composições e métodos compreendendo proteases microbianas variantes |
| WO2011006915A2 (en) * | 2009-07-16 | 2011-01-20 | Glaxo Group Limited | Improved anti-serum albumin binding single variable domains |
-
2010
- 2010-07-14 WO PCT/EP2010/060112 patent/WO2011006915A2/en not_active Ceased
- 2010-07-14 CA CA2768462A patent/CA2768462A1/en not_active Abandoned
- 2010-07-14 EP EP10734965A patent/EP2454285A2/en not_active Withdrawn
- 2010-07-14 SG SG2012001855A patent/SG177601A1/en unknown
- 2010-07-14 KR KR1020127003939A patent/KR20120038494A/ko not_active Withdrawn
- 2010-07-14 IN IN640DEN2012 patent/IN2012DN00640A/en unknown
- 2010-07-14 BR BR112012001681A patent/BR112012001681A2/pt not_active IP Right Cessation
- 2010-07-14 AU AU2010272590A patent/AU2010272590B2/en not_active Ceased
- 2010-07-14 MX MX2012000765A patent/MX2012000765A/es not_active Application Discontinuation
- 2010-07-14 JP JP2012520016A patent/JP2012532620A/ja active Pending
- 2010-07-14 US US13/384,316 patent/US8679496B2/en not_active Expired - Fee Related
- 2010-07-14 CN CN2010800414331A patent/CN102574914A/zh active Pending
- 2010-07-14 EA EA201270174A patent/EA201270174A1/ru unknown
-
2012
- 2012-01-12 IL IL217520A patent/IL217520A0/en unknown
- 2012-01-13 ZA ZA2012/00276A patent/ZA201200276B/en unknown
-
2014
- 2014-01-30 US US14/168,168 patent/US20140140996A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2011006915A3 (en) | 2011-03-03 |
| CA2768462A1 (en) | 2011-01-20 |
| CN102574914A (zh) | 2012-07-11 |
| AU2010272590B2 (en) | 2013-10-10 |
| MX2012000765A (es) | 2012-02-13 |
| EP2454285A2 (en) | 2012-05-23 |
| US8679496B2 (en) | 2014-03-25 |
| US20120114647A1 (en) | 2012-05-10 |
| JP2012532620A (ja) | 2012-12-20 |
| EA201270174A1 (ru) | 2012-07-30 |
| WO2011006915A2 (en) | 2011-01-20 |
| US20140140996A1 (en) | 2014-05-22 |
| SG177601A1 (en) | 2012-02-28 |
| ZA201200276B (en) | 2012-09-26 |
| BR112012001681A2 (pt) | 2019-09-24 |
| AU2010272590A1 (en) | 2012-02-02 |
| KR20120038494A (ko) | 2012-04-23 |
| IL217520A0 (en) | 2012-02-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2012000765A (es) | Dominios variables sencillos de union de albumina anti-suero mejorados. | |
| MX2011008752A (es) | Variantes de union a anti-albumina de suero mejoradas. | |
| MX2012013406A (es) | Variantes de union mejoradas anti-albumina serica. | |
| MX2011008749A (es) | Variantes de union a anti-albumina de suero mejoradas. | |
| WO2012072731A3 (en) | Improved anti-serum albumin binding single variable domains | |
| CY1119567T1 (el) | Θεραπευτικα πεπτιδια | |
| WO2014083208A9 (en) | Binding proteins comprising at least two repeat domains against her2 | |
| WO2014144791A3 (en) | Therapeutic peptides | |
| MX2012003939A (es) | Fusiones y conjugados de farmaco. | |
| WO2013072813A3 (en) | Cytotoxic peptides and antibody drug conjugates thereof | |
| UA106900C2 (uk) | Агоністичний dr5-зв'язувальний поліпептид | |
| WO2011086143A3 (en) | Liver targeting domain antibodies | |
| MX2013002055A (es) | Variantes anti-enlace de albumina de suero mejodas. | |
| WO2011112566A3 (en) | Basigin binding proteins | |
| WO2018062402A8 (en) | CMET MONOCLONAL BINDING AGENTS, THEIR MEDICINAL CONJUGATES AND USES THEREOF | |
| WO2016005474A8 (en) | Site selective conjugation of an oligonucleotide conjugate or a small molecule to a metal binding protein | |
| WO2014044793A3 (en) | Cd22-binding peptides | |
| MX2015014198A (es) | Anticuerpos cuyo objetivo es m-csf. | |
| WO2012136792A3 (en) | Cck compositions | |
| CR20110473A (es) | Variantes de union a anti-albúmina de suero mejoradas. | |
| HK1196856A (en) | C10rf32 antibodies, and uses thereof for treatment of cancer | |
| HK1171028A (en) | Il-17 binding compounds and medical uses thereof | |
| TH148778A (th) | เปปไทด์รักษาโรค |